µå·¯±×ÀÎÆ÷¸ÞÀÎ
 

»óº´Äڵ忡 µû¸¥ »óº´¸íÀ» È®ÀÎ ÇϽǼö ÀÖ½À´Ï´Ù.  
»óº´ÄÚµå ÇÑ±Û»óº´¸í ¿µ¹®»óº´¸í
Y402 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ŭ·Î¶÷Æä´ÏÄÝÁ· Chloramphenicol group causing adverse effects in therapeutic use
Y403 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¸¶Å©·Î¸®µå Macrolides causing adverse effects in therapeutic use
Y404 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Å×Æ®¶ó»çÀÌŬ¸° Tetracyclines causing adverse effects in therapeutic use
Y405 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¾Æ¹Ì³ë±Û¸®ÄÚ»çÀ̵å Aminoglycosides causing adverse effects in therapeutic use
Y405 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ½ºÆ®·¾Å丶À̽ŠStreptomycin causing adverse effects in therapeutic use
Y406 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¸®Æĸ¶À̽ŠRifamycins causing adverse effects in therapeutic use
Y407 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Àü½ÅÇ×Áø±ÕÇ×»ýÁ¦ Antifungal antibiotics, systemically used causing adverse effects in therapeutic use
Y408 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ Àü½ÅÇ×»ýÁ¦ Other systemic antibiotics causing adverse effects in therapeutic use
Y409 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ó¼¼ºÒ¸íÀÇ Àü½ÅÇ×»ýÁ¦ Systemic antibiotic, unspecified causing adverse effects in therapeutic use
Y41 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ Àü½Å Ç×°¨¿°Á¦ ¹× Ç×±â»ýÃæÁ¦ Other systemic anti-infectives and antiparasitics causing adverse effects in therapeutic use
Y410 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¼³Æù¾Æ¹Ìµå Sulfonamides causing adverse effects in therapeutic use
Y411 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×¹ÌÄÚ¹ÚÅ׸®¾ÆÁ¦ Antimycobacterial drugs causing adverse effects in therapeutic use
Y412 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç׸»¶ó¸®¾ÆÁ¦ ¹× ±âŸ Ç÷¾×³» ¿øÃæ·ù¿¡ ÀÛ¿ëÇÏ´Â ¾à¹° Antimalarials and drugs acting on other blood protozoa causing adverse effects in therapeutic use
Y413 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ Ç׿øÃæÁ¦ Other antiprotozoal drugs causing adverse effects in therapeutic use
Y414 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±¸ÃæÁ¦ Anthelminthics causing adverse effects in therapeutic use
Y415 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×¹ÙÀÌ·¯½ºÁ¦ Antiviral drugs causing adverse effects in therapeutic use
Y418 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ¸í½ÃµÈ Àü½Å Ç×°¨¿°Á¦ ¹× Ç×±â»ýÃæÁ¦ Other specified systemic anti-infectives and antiparasitics causing adverse effects in therapeutic use
Y418 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÇÏÀ̵å·Ï½ÃÄû³ë¸° À¯µµÃ¼ Hydroxyquinoline derivatives causing adverse effects in therapeutic use
Y419 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ó¼¼ºÒ¸íÀÇ Àü½Å Ç×°¨¿°Á¦ ¹× Ç×±â»ýÃæÁ¦ Systemic anti-infective and antiparasitic, unspecified causing adverse effects in therapeutic use
Y42 Ä¡·á½Ã ºÎÀÛ¿ëÀ» ³ªÅ¸³»´Â ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº È£¸£¸ó ¹× ±×µéÀÇ ÇÕ¼º ´ë¿ëÇ° ¹× ´ëÇ×Á¦(±æÇ×Á¦) Hormones and their synthetic substitutes and antagonists,NEC causing adverse effects in therapeutic use
3871  3872  3873  [3874] 3875  3876  3877  3878  3879  3880